Recommendations for the Management of Chronic Visceral Pain – Cindy Lampner – July 05, 2016
The subjective experience of visceral pain and the neurobiological mechanisms that underlie it are substantially different from those of somatic pain, yet pain management strategies do not traditionally differ in their approaches.
As a result, the treatment of visceral pain frequently results in suboptimal outcomes and adverse effects on the GI tract.
Frequently diffuse, poorly localized and associated with autonomic and emotional reactions and alterations in visceral function, visceral pain is common across a range of clinical populations. Continue reading
Food additives promote inflammation, colon cancer in mice | National Institutes of Health (NIH)
Our digestive tracts are home to trillions of microbes, including bacteria, fungi, and viruses.
This microbial community, collectively known as the gut microbiota, plays a role in illness and health. Changes in these microbes have been associated with several diseases
Dietary emulsifiers, which are chemically similar to detergents, are added to many processed foods to improve texture and extend shelf life. Continue reading
Gastroparesis from http://www.aboutgimotility.org
Gastroparesis is a disorder in which the stomach empties very slowly.
Gastroparesis most often occurs when the nerves to the stomach are damaged or don’t work properly
Gastroparesis can also occur after stomach surgery for other conditions.
Other causes of gastroparesis include Parkinson’s disease and some medications, especially narcotic pain medications. Continue reading
Indicator of chronic fatigue syndrome found in gut bacteria – June 24, 2016 – Cornell Univ – By Krishna Ramanujan
Physicians have been mystified by chronic fatigue syndrome, a condition where normal exertion leads to debilitating fatigue that isn’t alleviated by rest. There are no known triggers, and diagnosis requires lengthy tests administered by an expert.
Now, for the first time, Cornell researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
In a study published June 23 in the journal Microbiome, the team describes how they correctly diagnosed myalgic encephalomyeletis/chronic fatigue syndrome (ME/CFS) in 83 percent of patients through stool samples and blood work, offering a noninvasive diagnosis and a step toward understanding the cause of the disease. Continue reading
Gut bacteria regulate nerve fibre insulation | Science | The Guardian | Mo Costandi | Tuesday 5 April 2016
Far from being silent partners that merely help to digest food, the bacteria in your gut may also be exerting subtle influences on your thoughts, moods, and behaviour.
And according to a new study from researchers at University College Cork, your gut microbes might affect the structure and function of the brain in a more direct way, by regulating myelination, the process by which nerve fibres are insulated so that they can conduct impulses properly. Continue reading
Using alternative and complementary treatments to manage IBS – Harvard Health
Because there is no cure for IBS, treatment aims to control individual symptoms. As a result, the management of IBS requires a great amount of understanding between doctor and patient.
Patients need to educate themselves about IBS and receive adequate information from their physicians so they can learn to manage the syndrome and regain control over their lives.
You can play an active role in managing your own condition. Begin with these measures: Continue reading
The difference between diverticulosis and diverticulitis – Harvard Health
Diverticula are pouch-like structures that form in the wall of the large intestine. When the large intestine contains diverticula, the condition is called diverticulosis. It is usually harmless and causes no problems.
When these pouches bleed or become inflamed or infected, the condition is called diverticulitis. Diverticulitis can cause a variety of symptoms, from abdominal pain and cramping to fever.
Visceral Pain and Gastrointestinal Microbiome | J Neurogastroenterol Motil. 2015 Apr
A complex set of interactions between the microbiome, gut and brain modulate responses to visceral pain.
These interactions occur at the level of the gastrointestinal mucosa, and via local neural, endocrine or immune activity; as well as by the production of factors transported through the circulatory system, like bacterial metabolites or hormones.
Various psychological, infectious and other stressors can disrupt this harmonious relationship and alter both the microbiome and visceral pain responses. Continue reading
Ehlers Danlos UK – Gastro and EDS from Ehlers-Danlos Support UK
The gastrointestinal (GI) manifestations of EDS, and in particular EDS-HM/JHS, whilst often reported by patients have, until the recent past, received scant attention from the clinical and academic communities alike.
This is likely to be a consequence of the increasing trend of sub-specialisation within medical practice, which often leads to a variety of disorders being managed in isolation within super-specialised clinics despite evidence that such disorders may actually represent a more generalised pathology. Continue reading
Manage Your Pain Safer & Smarter | National Pain Report
Last week I was called in to see a 45-year-old otherwise healthy female who was admitted to the emergency department following two bouts of having vomited blood. She was an avid exerciser, had recently sprained her ankle and had lately been taking prescribed naproxen 500 mg twice daily, for the last 7 days.
The only other medication she was taking was daily low-dose aspirin, 325 mg per day; because someone had told her that taking an aspirin per day would be good for her hear